KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Please contact us if you have any questions about Integration & Separation or on any other matter.
Hong Kong
Dominic Orchard
Partner, Head of ASPAC Integration & Separation Advisory
+852 2140 2262 / Fax +852 2973 6616
Shanghai
Wei Lin
Partner
+86 (21) 2212 3508
Beijing
Luther Kang
Senior Manager
+86 (10) 8508 5867
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.